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Introduction
Colorectal carcinoma is one of the leading causes of
death in the elderly. About 20% of patients present with
liver metastasis at the time of diagnosis1. The other
common metastatic sites of colorectal carcinoma include
the lungs, bone and brain2. Splenic metastases from
colorectal carcinomas are rare and usually occur in
association with other extensive metastasis3. Isolated
splenic metastasis from colorectal carcinoma is unusual
with only a couple of dozen cases4,5. Although resection
of liver metastasis from colorectal carcinoma may
benefit some patients1, the role of resection in syn-
chronous isolated splenic metastasis is not well known.
We report the case of an old man with synchronous
isolated splenic metastasis from colorectal carcinoma
treated by left hemicolectomy and splenectomy.
Case Report
An 84-year-old man presented with intermittent tarry
stool and bloody stool for 1 week. He also complained of
general fatigue, dizziness, and epigastric fullness. Physical
examination revealed mild splenomegaly, and the liver
was not palpable. The rectal examination was also unre-
markable. Iron deficiency anemia was identified by
hematocrit (20.4%; reference range, 40–54%), low mean
corpuscular volume (56.8 fL; reference range, 80–98 fL),
low serum iron level (17μg/dL; reference range, 49–181
μg/dL), and low serum ferritin level (29 ng/dL; reference
range, 30–400ng/dL). Esophagogastroduodenoscopy was
unremarkable, and colonoscopy demonstrated proximal
sigmoid colon stricture and several hyperemic nodular
and polypoid lesions situated 30 cm from the anal
verge. Pathology of these nodular lesions was adenocar-
cinoma. Subsequent abdominal sonography revealed
one ill-defined hyperechoic nodule in the spleen. Com-
puted tomography of the abdomen and pelvis  (Figure 1)
showed evidence of short segmental annular wall thick-
ening at the sigmoid colon and splenic flexure favoring
multifocal colonic carcinoma, and one hypovascular
tumor in the spleen, more in favor of splenic metastasis.
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SUMMARY
The most common site of metastasis from colorectal carcinoma is the liver. Isolated splenic metastasis from
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tomography. The patient underwent left hemicolectomy and splenectomy, and histology of spleen confirmed
a metastatic adenocarcinoma from colonic carcinoma. The literature recommends close attention to the spleen
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At laparotomy, one annular tumor was in the sig-
moid colon. The other tumor at the splenic flexure of
colon was adhered and invaded to the small intestine
and omentum. However, the spleen showed no evidence
of direct tumor invasion. The patient underwent sub-
sequent left hemicolectomy as well as wedge resection
of the small intestine and splenectomy.
On histopathologic examination, the colonic tumor
at the splenic flexure showed a moderately differentiated
intestinal-type adenocarcinoma composed of single and
fused malignant glands lined by tall columnar intestinal-
type neoplastic cells in all layers of the colonic wall that
directly invaded to the adjacent jejunum (T4). Immunos-
taining showed that the tumor cells were cytokeratin
(CK) 7-negative and CK 20-positive. Eight of 18 excised
regional lymph nodes were positive for metastasis (N2).
The spleen measured 12×10×6cm and weighed 300g.
Sections of the spleen (Figure 2) revealed multiple meta-
static tumors in the splenic parenchyma (the largest
tumor was 4cm at the greatest dimension; M1). The mor-
phology of the splenic tumors revealed intestinal-type
adenocarcinomas  (Figure 3) with CK 7-negative and CK
20-positive tumor cells, similar to the colonic tumor at the
splenic flexure, and consisted of a metastatic moderately
differentiated adenocarcinoma from colon to spleen.
The postoperative course was uneventful, and the
patient was discharged 2 weeks later.
Discussion
When metastasis is present in a colorectal carcinoma,
it is usually liver metastasis1. Hence, discovering a
splenic tumor in our patient was unexpected. Berge3
reported the incidence of splenic metastasis as 2% of
1,019 autopsy cases with colon and rectal carcinomas,
and all had other organ metastasis. Isolated splenic
metastases from colorectal carcinoma are rare and, to
the best of our knowledge, there are only three cases
of synchronous isolated splenic metastasis4. As with
our case, the left colon was the primary site in these
cases.
Splenic metastasis from various tumors revealed
minor symptoms, including weight loss, epigastric pain,
splenomegaly, left hypochondriac pain, hypersplenism
and spontaneous rupture5,6. Our patient’s presentation
involved nonspecific epigastric pain, and it is impossi-
ble to know whether the symptoms were caused by
the splenic tumor. In such cases, it is not unusual to
order abdominal ultrasound, especially in patients
with a high suspicion of colorectal carcinoma. Using
ultrasound, Ishida et al.7 reported four cases of isolated
splenic metastasis from colorectal carcinoma. Thus,
they concluded that it was necessary to pay attention
to the spleen in the colonic carcinoma patient either
in preoperative or follow-up examinations.
The reason that the spleen seems resistant to
metastasis is unclear, and several theories have been
proposed. Sappington8 explained that the low frequency
of splenic metastasis may relate from the sharp angle
of the splenic artery with celiac axis. Kettle9 suggested
that the rhythmic contraction of the spleen might pre-
vent malignant emboli from growing in that location.
Even if the tumor cells reach the spleen, they may be
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Figure 1. Computed tomography scan showing one hypo-
vascular tumor in the spleen.
Figure 2. Macroscopic view of the splenectomy specimen
revealing two tumors measuring up to 4 cm at the largest
diameter in the spleen. Note that the splenic capsule is free
of tumor invasion.
inhibited by the immune surveillance10. The absence of
afferent lymphatic vessels in the splenic parenchyma is
another possibility8. Although lymphatic vessels present
in capsular and subcapsular regions can cause subcap-
sular splenic metastasis11, most authors proposed that
splenic metastasis of colorectal cancer occurs via the
vascular routes, because the metastasis was limited
within the splenic parenchyma5. In either metachronous
or synchronous splenic metastasis from colorectal car-
cinoma, the left colon was the predominant site of the
primary tumor4. This phenomenon may be explained
by a possible retrograde action from the inferior mesen-
teric vein to the splenic vein and spleen12.
The long-term survival after splenectomy in patients
with metachronous splenic metastasis from colorectal
carcinoma varied from 6 months to 7 years5,13. The 1-
year survival rate was 86.6%, and median survival time
was 66.6 months5. As a result, most literature sug-
gested that splenectomies are justified in the presence
of metachronous isolated metastatic disease4,5,12–16.
Although splenectomies were performed in patients
with synchronous splenic metastasis from colorectal
carcinomas4,17, one of the patients died of diffuse car-
cinomatosis after 1 year and the other had liver metas-
tasis 6 months post-splenectomy. No definite conclusion
about the benefits of splenectomy in synchronous
splenic metastasis can be drawn, particularly because
this disease is such a rare entity. Nevertheless, the grow-
ing frequency of colorectal carcinoma warrants the
prospective collection in multiple centers with respect
to the safety and risk-benefit ratio of splenectomy.
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Figure 3. Histology section of spleen showing three groups
of metastatic adenocarcinoma (hematoxylin and eosin,
100×).
